It is forecasted in the global market that cannabidiol or CBD is going to hit $23.6 billion in revenue by 2025. With this data, the annual growth rate is expected to be at 22.2% when it reaches 2025. This looks very promising especially to businesses who are getting themselves into the CBD market because of its rising popularity.
In today’s global market, North America is leading with 40% but this might not be the case in the long run because Europe is closing the gap with 31% market share and it is being forecasted to surpass North America given its geographic demand.
As the demand for CBD gets bigger, more global companies are taking advantage to be the leader in innovation involving CBD. One of the global leaders in end-to-end development and manufacturing of cannabinoid-based products, The Valens Company is doing their best to position themselves first to meet the demands of the international market for CBD. These are made possible by offering innovative ideas and development like customisable services for plant processing and extraction.
CBD in Europe
Cannabis legality varies across Europe, with the majority allowing its use solely for medicinal grounds. CBD products produced from hemp are now legal for recreational use. Some are still operating in a legal gray area owing to differing definitions of what constitutes hemp. Product quality issues, inconsistency, and regulation have stifled industry expansion and jeopardized customer safety.
The CBD market in Europe is expected to reach its peak in November 2026, with an estimated value of €1.5 billion by 2023. A landmark ruling by the European Union’s Court of Justice determined that CBD is not a narcotic, enabling it to be marketed throughout the European Union. This decision has paved a clearer regulatory road for the legal use of CBD, benefiting firms that manufacture high-quality CBD products.
Beyond the market for typical CBD-forward cannabis products, Valens is working to improve wellness-focused product options. CBD products are expected to account for more than 0.15 per cent 7 of the entire health and wellness market by 2028. Valens intends to collaborate with companies to attract a new group of customers who have never used cannabis before. CBD’s potential for integration into the wellness category is infinite, thanks to technology breakthroughs and product innovation.
CBD product overview
Imitations and fraudulent product claims weaken the market potential for enterprises concentrating on quality, while law lags behind customer demand. Many consumers seek CBD in this fast-developing industry but are unsure how to choose the finest product for them since they are inexperienced with the industry. Consumer education and quality assurance are critical for firms investing in high-quality, compliant CBD products.
Cannabis (Cannabis sativa, L.) includes about 120 phytocannabinoids8, plant chemicals that can activate endocannabinoid receptors9. THC and CBD are the most frequently used and researched cannabinoids, although research on the medicinal potential of numerous lesser-known cannabinoids, such as cannabichromene (CBC) and cannabinol, is underway (CBN). CBD continues to stand out in terms of wellbeing due to its medicinal capabilities.
Potential wellness benefits
According to preliminary studies, CBD may provide a number of possible wellness advantages. The recent European Court of Justice judgement on CBD’s categorization as a non-narcotic opens the door to more substantial research options. In the EU, only one CBD-containing pharmaceutical product is authorised for use: Epidiolex®10, which is used as an additional treatment for seizures associated with Lennox-Gastaut and Dravet syndromes. Meanwhile, CBD has grown in popularity in the wellness sector due to its potential for pain relief11, relaxation12, and inflammation relief13.
CBD oil and hemp seed oil
Both CBD oil and hemp seed oil are non-intoxicating oils derived from the cannabis plant. They are, nevertheless, totally separate items in terms of development and market presentation. Hemp seed oil14 is derived only from hemp seeds and is extracted through cold pressing. Because hemp seeds contain little to no cannabinoids, they are not a known source of CBD. Hemp seed oil, which is high in omega-3 and omega-6 fatty acids, can give a variety of nutritional advantages when consumed. It is, however, used topically to treat dry skin15.
CBD oil, also known as hemp extract, is extracted from the cannabis plant using a solvent such as CO2 or ethanol. CBD may be obtained from the plant’s flowering heads or removed from the plant in its whole. Some producers assert that hemp seed oil products provide the same potential advantages as CBD..
Comparing hemp and cannabis-derived CBD
Another cause of uncertainty with CBD is the plant itself. Hemp and drug-type cannabis are both derived from the same plant species, Cannabis sativa L. Any cannabis plant that has more than 0.2 percent THC (on a dry weight basis) is deemed as drug-type cannabis in Europe. Anything below that point is considered hemp.
The resin16 released by cannabis plants maintains stable cannabinoid ratios, implying that drug-type cannabis, with its greater content of THC, often generates proportionately more CBD by volume than hemp. CBD is constant at the molecular level regardless of plant source.
Because validated testing is not required, the marketed CBD level of many cannabis products frequently does not match their actual measured CBD concentration. For example, a recent17 study of 29 over-the-counter CBD products in the UK discovered that the majority of the items tested (62%) did not contain CBD levels within 10% of the quantity specified on the label. This evidence validates prior comparative studies18 on labeling inaccuracy, with findings ranging from 0% to 155% of what was on the product label. Ineffectiveness and bad experiences, on the other hand, might occur from mislabeled goods, leading to a lowered customer awareness of possible CBD advantages. Validated potency testing and correct labeling are consequently critical for establishing customer trust.
Extraction and processing
Initial extractions often yield an oleoresin high in cannabinoids and terpenes. Before being considered an ingredient, this extract must be winterized to remove impurities (waxes and lipids), and purification can be undertaken if required to eliminate terpenes and cannabinoids other than CBD. For example, the winterized resin can be distilled to make a purified CBD distillate free of terpenes or refined further using crystallization or chromatography to generate a CBD isolate that is 99 percent pure CBD and free of other cannabinoids. Based on the type of completed product and desired features, different purities of extracts are utilized.
CBD oils and isolates
Previously, the CBD business was defined by a desire for edible oils. As a result of processing, there are some significant changes between types of oils and their composition:
- Full-spectrum CBD is the product with the most similar composition to the beginning material. It comprises cannabinoids, flavonoids, and terpenes – if THC is present in the beginning material, it will also be present in the product.
- Broad-spectrum CBD oil is built the same way as full-spectrum oil, except THC is eliminated from the substance.
- CBD distillates are greater distilled CBD that has been refined to eliminate flavor and odor — distillates are frequently used in vaporizer cartridges, sweets, and topicals.
- CBD isolates CBD in its purest form, usually in the form of a powder or crystal.
Integrating CBD into additional products
Miscibility is a barrier to integrating CBD oil into wellness goods: putting an oil-based component into products that are typically water-based creates the difficulty of product separation. If not controlled appropriately, this might result in uneven dose and erroneous labelling. Valens found a solution to this challenge by acquiring a broader license to create and market products based on SōRSE™ technology. Valens provides European partners with the capacity to convert any CBD oil into a water-soluble emulsion in foreign markets.
A stable mixing of oil-soluble (CBD) and water-soluble substances is an emulsion. Valens’ SōRSE is an emulsion technology that is shelf-stable for up to 12 months. SōRSE eliminates product variability through reproducible design, resulting in uniform CBD emulsions. Valens products containing SōRSE are not subject to usual issues about product separation, such as creaming, clarity, and/or sedimentation.
SōRSE by Valens, which is available in liquid, ordinary powder, and agglomerated powder forms, enables easy CBD incorporation into nearly any product. It is fully customizable and may also be used to create unique product-specific formulas. Customer tastes and smells can be achieved with a modest sensory effect.
The CBD consumables21 industry is rapidly increasing, with products ranging from CBD sweets to drinks and gel-capsule supplements. Valens products created with SōRSE are not prone to common product separation issues such as creaming, clarity, and/or sedimentation. CBD may be infused into practically any food or beverage product using SōRSE by Valens technology, with food-grade quality control, safety, and predictability. Because of their discretion and convenience of use, ingestibles are popular among consumers. Consumers utilized items that matched their lives in the wellness area as well. Valens caters to this desire by offering customizable product formats including carbonated drinks, drink drops, cans, bottles, and tiny format shots, all of which are free of the odor and taste of cannabis.
CBD-infused topical health products come in a range of formats, such as lotions, creams, balms, and sprays. At the site of administration, these chemicals can activate endocannabinoid receptors in muscle tissue, skin, and neurons.
Much recent study has concentrated on endocannabinoid receptors in the skin. Cannabinoids are active in maintaining skin homeostasis, including inflammation, barrier development, and regulation, based on preclinical research, sparking interest in CBD’s potential as a topical therapeutic for improving skin wellness.
Quality topicals have various advantages that go beyond a single component. Valens enhances ordinary product compositions and the customer experience by using consumer-trusted, ethically, and sustainably sourced ingredients like soothing aloe and nourishing shea butter.
Personal care products
CBD wellness products can also be used in a wide range of businesses, with lots of opportunities for innovation and new product development. Popular product categories include bath bombs, body rubs, massage oils, and intimate products.Many of these products can induce relaxation or relieve hurting muscles, but their effectiveness is restricted by their delivery technique. Valens formulas are the result of rigorous research and development, working in conjunction with tried-and-true components like menthol and arnica flower.
Inhalation and vaporisers
Vaporizers have remained popular because of their quick effects, confidentiality, and mobility. CBD enters the lungs via inhalation and travels to the circulation, where it circulates to the brain and other parts of the body. Unlike edibles, which undergo first-pass digestion in the liver, CBD inhaled is delivered directly to the brain.
As an industry leader in vaporizer production, Valens provides a complete solution for customizable, white-label vape goods. Valens upholds stringent quality standards for customer safety while providing a diverse range of hardware solutions, such as universal cartridges and disposable units.
Consumer trust and testing
CBD products are not created equal. In a recent study25 of 67 CBD food items, THC contamination above the lowest recognized effects threshold was found in 25% of samples. Consumers who buy THC-containing products under the idea that they are THC-free are in danger of experiencing negative experiences, which may cause them to leave the product.
There is an opportunity on the market for goods that have not been extensively examined because of the imprecise definition of hemp and the lack of a necessity for validated testing. Due to poor testing, other contaminants such as heavy metals, microorganisms, pesticides, mycotoxins, and residual solvents may also go undetected.
Valens Labs is an analytical testing laboratory that specializes in quality control. Valens Labs has collaborated with Thermo Fisher Scientific to develop a Center of Excellence in Plant-Based Science. Valens Labs is ISO 17025 certified and adheres to a gold standard in laboratory testing services, exceeding even the most strict restrictions to offer industry-leading findings.
Your partner in wellness
Due to a lack of clarity in the legislation and surrounding limitations imposed on CBD products circulating in the nation, safe market development in Europe has been constrained. As a result, individuals were exposed to deceptive marketing of product claims and assertions with an allegedly low degree of authenticity through various media, as well as the introduction of items into commerce that did not follow or comply with safety rules.
The demand for CBD products in wellness will continue to rise in tandem with the legislative shift toward laws and norms, which will necessitate product quality assurance and label accuracy. Accordingly, this would benefit and offer additional chances for existing companies in the health and wellness, food and beverage, and cosmetic industries.
The Valens Company wants to be the chosen partner for quality-conscious worldwide enterprises. By utilizing a one-stop-shop business model, wellness firms may benefit from Valens’ extensive knowledge in cannabinoid-based research and technology.
Valens exclusively uses best-in-class extraction and analytical testing to provide the highest quality extracts. To meet the growing wellness market’s expectations, the firm also offers a broad variety of services such as formulation, product development, white labelling, and customized manufacture. Partners can be certain that their goods will be lawful and free of toxins and fillers.
SHOP NOW – https://cbdsanctuary.uk/shop/